Canadian intraoperative MRI technology developer IMRIS of Winnipeg, Manitoba, has received clearance from the U.S. Food and Drug Administration (FDA) for its 3-tesla IMRISneuro.
IMRISneuro is now available with either a 1.5-tesla or 3-tesla magnet. Both versions utilize an MRI system from Siemens Healthcare of Malvern, PA.
Related Reading
IMRIS names Rice to U.S. sales post, May 30, 2008
IMRIS receives Oregon order, April 28, 2008
IMRIS wins Chinese contract for MR suite, February 1, 2008
IMRIS completes IPO, November 2, 2007
Copyright © 2008 AuntMinnie.com